| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Pelitinib (EKB-569) |
|---|
| Description | Pelitinib is a pan-ErbB tyrosine kinase inhibitor with potential anticancer activity. Pelitinib irreversibly binds covalently to epidermal growth factor receptors (EGFR) ErbB-1, -2 and -4, thereby inhibiting receptor phosphorylation and signal transduction and resulting in apoptosis and suppression of proliferation in tumor cells that overexpress these receptors. MW: 467.92. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide |
|---|
| Gene, Accession, CAS # | CAS: 257933-82-7 |
|---|
| Catalog # | 2676-25 |
|---|
| Price | |
|---|
| Order / More Info | Pelitinib (EKB-569) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|